Regenerative Medicine Industry News

WHERE INNOVATION AND REGENERATIVE MEDICINE MEET

Industry NewsAccess human allograft tissue and regenerative medicine industry news.

29Dec

FDA Recognition of BioLab Holdings Amniotic Membrane Allografts

The FDA’s Tissue Reference Group recognized five new amniotic membrane allograft products as human cell/tissue products (HCT/Ps), validating their regulatory pathway and clinical use.
Read More
16Dec

Cellution Biologics Inc. Announces First Peer-Reviewed Publication Demonstrating Positive Outcomes for AmchoPlast™ in the Treatment of Chronic Diabetic Foot Ulcers

Cellution Biologics, Inc., a leader in regenerative allograft solutions, proudly announces the publication of its first peer-reviewed clinical article, which presents interim results from two prospective, randomized, multicenter clinical studies evaluating AmchoPlast™ dehydrated human amnion-intermediate layer-chorion membrane (dHAICM) allograft.
Read More

Third Party Sites

The Site may provide hyperlinks to third party websites or access to third party content. This content is NOT intended to characterize SurgiLogix allografts for distribution. SurgiLogix does not control, endorse, or guarantee content found in such sites. You agree that SurgiLogix is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that SurgiLogix shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.